exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular Grafts— 510(k) K233783

Name: FDA 510(k) clearance K233783
Creator: U.S. Food and Drug Administration
Published: 2024-01-17

Substantially Equivalent

Peca Labs, Inc.

FDA 510(k) clearance K233783 for exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular Grafts, Substantially Equivalent on 2024-01-17. Applicant: Peca Labs, Inc.. Device class: 2.

Clearance details

Applicant: Peca Labs, Inc.
Product code: Code DSY
Device class: Class 2
Regulation: 21 CFR 870.3450
Advisory panel: Cardiovascular
Date received: 2023-11-27
Decision date: 2024-01-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Pittsburgh, PA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DSY

view all

K252445 — Fusion Bioline Vascular Graft2026-04-27
K252277 — Spiral Laminar Flow Vascular Arteriovenous Graft (AV0645)2025-10-20
K241550 — Gelweave Vascular Prostheses2025-02-27
K241070 — Gelsoft Plus Vascular Prostheses2024-11-15
K231972 — Advanta VXT Vascular Graft, Flixene Vascular Graft2024-03-28

Adverse events under product code DSY

product code DSY

Death: 29
Injury: 694
Total: 723

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.